Custom Health Launches Opioid Addiction Deterrence Task Force

Custom Health Inc. celebrated the launch of the Opioid Addiction Deterrence Task Force (OADTF) by the American Medical Technology Coalition (AMTC). This initiative aims to combat the opioid crisis through cutting-edge research, technology, and strategic partnerships. The OADTF will focus on preventing opioid addiction and supporting recovery.

Prescription opioids are a major factor in the U.S. opioid epidemic. In 2023, 150 million opioid prescriptions were dispensed, affecting nearly half of Americans. Proper clinical monitoring is crucial to manage pain and reduce addiction risks. The OADTF will bring experts and technology innovators together to tackle these issues.

The OADTF has four main goals: leveraging innovative technologies, advocating for effective policies, committing to research and education, and engaging with communities. This summer, the Task Force will launch briefings to focus on accelerating opioid addiction deterrence strategies.

Shane Bishop, CEO of Custom Health, stated that the goal is to use medical technology to deter addiction safely and provide rapid support to those affected by opioid use disorder.